|
GB9203689D0
(en)
*
|
1992-02-20 |
1992-04-08 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB9310030D0
(en)
*
|
1993-05-15 |
1993-06-30 |
Scras |
Dry processed particles and process for the preparation of the same
|
|
GB9505032D0
(en)
*
|
1995-03-13 |
1995-05-03 |
Westminster Lab Ltd |
Improvements in or relating to organic compositions
|
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
CA2236175A1
(en)
*
|
1995-11-02 |
1997-05-09 |
Merck Frosst Canada Incorporated |
New technology for wet granulation
|
|
AU732112B2
(en)
*
|
1996-12-12 |
2001-04-12 |
Dds Drug Delivery Service Gesellschaft Zur Forderung Der Forschung In Pharmazeutischer Technologie Und Biopharmazie Mbh |
Formulation in the form of a matrix material-excipient compound, matrix material-active substance compound and/or matrix material-excipient-active substance compound, and processes for the preparation thereof and the use thereof for the preparation of tablets and/or other larger matrix units
|
|
US5980882A
(en)
*
|
1997-04-16 |
1999-11-09 |
Medeva Pharmaceuticals Manufacturing |
Drug-resin complexes stabilized by chelating agents
|
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
|
US5916595A
(en)
*
|
1997-12-12 |
1999-06-29 |
Andrx Pharmaceutials, Inc. |
HMG co-reductase inhibitor
|
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
|
IT1298574B1
(it)
*
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione
|
|
US7122207B2
(en)
*
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
|
UA69413C2
(uk)
|
1998-05-22 |
2004-09-15 |
Брістол-Майерс Сквібб Компані |
Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
|
|
UA73092C2
(uk)
|
1998-07-17 |
2005-06-15 |
Брістол-Майерс Сквібб Компані |
Таблетка з ентеросолюбільним покриттям і спосіб її приготування
|
|
DE19855440A1
(de)
*
|
1998-12-01 |
2000-06-08 |
Basf Ag |
Verfahren zum Herstellen fester Darreichungsformen mittels Schmelzextrusion
|
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
|
MXPA02000725A
(es)
*
|
1999-07-29 |
2003-07-14 |
Roxane Lab Inc |
Formulacion opioide de liberacion sostenida.
|
|
US20030225124A1
(en)
*
|
1999-08-31 |
2003-12-04 |
Spiridon Spireas |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
US6555551B1
(en)
|
1999-08-31 |
2003-04-29 |
Mutual Pharmaceutical Co., Inc. |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
US20040157911A1
(en)
*
|
1999-08-31 |
2004-08-12 |
Spiridon Spireas |
Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
|
|
US6764694B1
(en)
*
|
1999-08-31 |
2004-07-20 |
Mutual Pharmaceutical Co., Inc. |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
DE10008506A1
(de)
*
|
2000-02-24 |
2001-09-13 |
Bayer Ag |
Verfahren zur Herstellung von pharmazeutischen Darreichungsformen
|
|
USRE44578E1
(en)
|
2000-04-10 |
2013-11-05 |
Teva Pharmaceutical Industries, Ltd. |
Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
|
|
PT2382970E
(pt)
*
|
2000-04-10 |
2013-02-18 |
Teva Pharma |
Composições farmacêuticas estáveis que contêm ácidos 7- substituído-3,5-dihidroxiheptanóicos ou ácidos 7-substituído- 3,5-dihidroxiheptenóicos
|
|
US20050106267A1
(en)
|
2003-10-20 |
2005-05-19 |
Framework Therapeutics, Llc |
Zeolite molecular sieves for the removal of toxins
|
|
US7387793B2
(en)
*
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
|
DE102005042875A1
(de)
*
|
2004-12-23 |
2006-09-21 |
Grünenthal GmbH |
Schnell freisetzende Darreichungsformen für Antibiotika
|
|
US8318230B2
(en)
*
|
2005-05-02 |
2012-11-27 |
Henkel Ag & Co. Kgaa |
Use of debranched starch in extrusion-spheronization pharmaceutical pellets
|
|
EP2474308A1
(en)
|
2005-06-27 |
2012-07-11 |
Valeant International (Barbados) SRL |
Pharmaceutical formulations containing bupropion hydrobromide
|
|
US20090246276A1
(en)
|
2008-01-28 |
2009-10-01 |
Graham Jackson |
Pharmaceutical Compositions
|
|
BRPI0918499A2
(pt)
*
|
2008-09-02 |
2015-12-01 |
Usv Ltd |
polímeros reticulados
|
|
US20130230586A1
(en)
|
2010-10-02 |
2013-09-05 |
Link Research & Grants Corporation |
Treatment of Tinnitus and Related Auditory Dysfunctions
|
|
SG190029A1
(en)
|
2010-11-04 |
2013-06-28 |
Albireo Ab |
Ibat inhibitors for the treatment of liver diseases
|
|
US20120308895A1
(en)
|
2011-05-31 |
2012-12-06 |
General Electric Company |
Electrode compositions useful for energy storage devices and other applications; and related devices and processes
|
|
KR20220082931A
(ko)
|
2014-06-25 |
2022-06-17 |
이에이 파마 가부시키가이샤 |
고형 제제 및 그의 착색 방지 또는 착색 감소 방법
|
|
EP3012252A1
(en)
|
2014-10-24 |
2016-04-27 |
Ferring BV |
Crystal modifications of elobixibat
|
|
US10786529B2
(en)
|
2016-02-09 |
2020-09-29 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10441605B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10441604B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
|
WO2017138876A1
(en)
*
|
2016-02-09 |
2017-08-17 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
|
EP3664781A1
(en)
|
2017-08-09 |
2020-06-17 |
Albireo AB |
Cholestyramine granules, oral cholestyramine formulations and use thereof
|
|
CN110996915B
(zh)
*
|
2017-08-09 |
2023-10-03 |
阿尔比里奥公司 |
考来烯胺丸粒、口服考来烯胺制剂及其用途
|
|
CN107552777A
(zh)
*
|
2017-09-05 |
2018-01-09 |
昆山玛冀电子有限公司 |
一种用于电感生产的粉末颗粒成分及生产工艺
|
|
WO2019087084A1
(en)
|
2017-11-02 |
2019-05-09 |
Eman Biodiscoveries Sd. Bhd. |
Extract of orthosiphon stamineus, formulations, and uses thereof
|
|
US10793534B2
(en)
|
2018-06-05 |
2020-10-06 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
CN112449637B
(zh)
|
2018-06-05 |
2024-03-19 |
阿尔比里奥公司 |
苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
US11801226B2
(en)
|
2018-06-20 |
2023-10-31 |
Albireo Ab |
Pharmaceutical formulation of odevixibat
|
|
FI3810581T3
(fi)
|
2018-06-20 |
2025-02-28 |
Albireo Ab |
Odeviksibaatin kiteiset modifikaatiot
|
|
US11549878B2
(en)
|
2018-08-09 |
2023-01-10 |
Albireo Ab |
In vitro method for determining the adsorbing capacity of an insoluble adsorbant
|
|
US11007142B2
(en)
|
2018-08-09 |
2021-05-18 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10722457B2
(en)
|
2018-08-09 |
2020-07-28 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
HRP20230039T1
(hr)
|
2019-02-06 |
2023-06-09 |
Albireo Ab |
Benzotiadiazepinski spojevi i njihova uporaba kao modulatora žučnih kiselina
|
|
US10975045B2
(en)
|
2019-02-06 |
2021-04-13 |
Aibireo AB |
Benzothiazepine compounds and their use as bile acid modulators
|
|
US10941127B2
(en)
|
2019-02-06 |
2021-03-09 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
BR112022010505A2
(pt)
|
2019-12-04 |
2022-09-06 |
Albireo Ab |
Compostos de benzotia(di)azepina e seu uso como moduladores do ácido biliar
|
|
US11014898B1
(en)
|
2020-12-04 |
2021-05-25 |
Albireo Ab |
Benzothiazepine compounds and their use as bile acid modulators
|
|
EP4069361B1
(en)
|
2019-12-04 |
2024-01-03 |
Albireo AB |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
CN114761018A
(zh)
|
2019-12-04 |
2022-07-15 |
阿尔比里奥公司 |
苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
CN114786772B
(zh)
|
2019-12-04 |
2024-04-09 |
阿尔比里奥公司 |
苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
CN116157389A
(zh)
|
2020-08-03 |
2023-05-23 |
阿尔比里奥公司 |
苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
JP2023549226A
(ja)
|
2020-11-12 |
2023-11-22 |
アルビレオ エービー |
進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット
|
|
JP2024500309A
(ja)
|
2020-12-04 |
2024-01-09 |
アルビレオ エービー |
ベンゾチア（ジ）アゼピン化合物および胆汁酸モジュレータとしてのその使用
|
|
TW202313579A
(zh)
|
2021-06-03 |
2023-04-01 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
|